|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 21 | 2022 | Efficacy and persistence between dimethyl fumarate, fingolimod, and ocrelizumab after natalizumab cessation | Zhu, C.; Kalincik, T.; Horakova, D.; Zhen, Z.; Buzzard, K.; Skibina, O.; Alroughani, R.; Izquierdo, G.; Eichau, S.; Kuhle, J.; Patti, F.; Grand'Maison, F.; Hodgkinson, S.; Grammond, P.; Lechner-Scott, J.; Butler, E.; Prat, A.; Girard, M.; Duquette, P.; Macdonell, R.; Weinstock-Guttman, B.; Ozakbas, S.; Slee, M.; Sa, M. Jose; Van Pesch, V.; Barnett, M.; VAN WIJMEERSCH, Bart; Gerlach, O.; Prevost, J.; Terzi, M.; Boz, C.; Laureys, G.; Van Hijfte, L.; Kermode, A.; Garber, J.; Yamout, B.; Khoury, S. J.; Jokubaitis, V.; Monif, M.; Merlo, D.; Van der Walt, A.; Butzkueven, H. | Journal Contribution | M |
| 22 | 2022 | Comparative effectiveness of autologous haematopoietic stem cell transplantation vs. fingolimod, ocrelizumab and natalizumab in relapsing-remitting MS | Kalincik, T.; Sharman, S.; Roos, I.; Freedman, M.; Atkins, H.; Burman, J.; Massey, J.; Sutton, I.; Withers, B.; Macdonell, R.; Grigg, A.; Torkildsen, O.; Bo, L.; Lehmann, A.; Horakova, D.; Havrdova, E.; Krasulova, E.; Trneny, M.; Kozak, T.; van der Walt, A.; Butzkueven, H.; McCombe, P.; VAN WIJMEERSCH, Bart; Buzzard, K.; Skibina, O.; Lechner-Scott, J.; Willekens, B.; Barnett, M.; Cartechini, E.; Ozakbas, S.; Alroughani, R.; Izquierdo, G.; Eichau, S.; Boz, C.; Kuhle, J.; Patti, F.; Terzi, M.; Prat, A.; Girard, M.; Duquette, P.; Grammond, P.; Onofrj, M.; Lugaresi, A.; Khoury, S.; Soysal, A.; Slee, M.; Prevost, J.; Turkoglu, R.; Sharrack, B.; Snowden, J. | Journal Contribution | M |
| 23 | 2022 | Cognitive improvements accompanied with WPAI improvements in OCR-treated patients with RRMS: 96-week CASTING data | Vermersch, P.; Comi, G.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Wiendl, H.; Buffels, R.; Kuenzel, T.; Benedict, R. | Journal Contribution | M |
| 24 | 2022 | Safety of Alemtuzumab in Patients with Multiple Sclerosis: Interim Results of a Post-Authorization Safety Study (PASS) | Montalban, X.; VAN WIJMEERSCH, Bart; Gobbi, C.; Robertson, N.; Klotz, L.; Achiron, A.; Lee, A.; Eichau, S.; Vecsei, L.; Benzerdjeb, H.; Rodrigues, A.; Jurgensen, S.; Chirieac, M.; Comi, G. | Journal Contribution | M |
| 25 | 2022 | Efficacy and safety of ocrelizumab is maintained in patients with RRMS with suboptimal response to prior disease-modifying therapies: 4-year NEDA data from CASTING-LIBERTO | Oreja-Guevara, C.; Benedict, R. H.; Comi, G.; Cutter, G.; Kister, I.; Siva, A.; Wiendl, H.; VAN WIJMEERSCH, Bart; Wuerfel, J.; El Azzouzi, B.; Buffels, R.; Dirks, P.; Kuenzel, T.; Vermersch, P. | Journal Contribution | M |
| 26 | 2022 | Early non-disabling relapses are associated with a higher risk of disability accumulation in people with relapsing-remitting multiple sclerosis | Daruwalla, C.; Shaygannejad, V.; Ozakbas, S.; Havrdova, E. K.; Alroughani, R.; Patti, F.; Onofrj, M.; Eichau, S.; Girard, M.; Grand'Maison, F.; Yamout, B.; Sajedi, S. A.; Amato, M. P.; Altintas, A.; Skibina, O.; Grammond, P.; Butzkueven, H.; Maimone, D.; Lechner-Scott, J.; Soysal, A.; John, N.; Gerlach, O.; Iuliano, G.; Foschi, M.; Van Pesch, V.; Cartechini, E.; Kuhle, J.; Sa, M. J.; Kermode, A.; Gouider, R.; Hodgkinson, S.; McCombe, P.; Sanchez-Menoyo, J. L.; Singhal, B.; Blanco, Y.; Hughes, S.; McGuigan, C.; Taylor, B.; Habek, M.; Al-Asmi, A.; Mihaela, S.; Castillo Trivino, T.; Al-Harbi, T.; Rojas, J. I.; Gray, O.; Khurana, D.; VAN WIJMEERSCH, Bart; Coles, A.; Kalincik, T.; Brown, J. W. L. | Journal Contribution | M |
| 27 | 2022 | Comparative effectiveness of autologous haematopoietic stem cell transplantation with immune reconstitution therapies in relapsing-remitting MS | Kalincik, T.; Sharmin , S.; Roos, I.; Freedman, M. S.; Atkins, H.; Burman, J.; Massey, J.; Sutton, I.; Withers, B.; Macdonell, R.; Grigg, A.; Torkildsen, O.; Bo, L.; Lehmann, A. K.; Horakova, D.; Havrdova, E. K.; Krasulova, E.; Trneny, M.; Kozak, T.; van der Walt, A.; Butzkueven, H.; VAN WIJMEERSCH, Bart; McCombe, P.; Buzzard, K.; Skibina, O.; Lechner-Scott, J.; Willekens, B.; Barnett, M.; Cartechini, E.; Izquierdo, G.; Eichau, S.; Patti, F.; Hodgkinson, S.; Prevost, J.; Onofrj, M.; Lugaresi, A.; Alroughani, R.; Butler, E.; Prat, A.; Girard, M.; Duquette, P.; Grammond, P.; Grand'Maison, F.; Laureys, G.; Van Hijfte, L.; Maimone, D.; Sharrack, B.; Snowden, J. | Journal Contribution | M |
| 28 | 2022 | Cognitive improvements in ocrelizumab-treated patients with relapsing-remitting multiple sclerosis: 96-week CASTING study data | Benedict, R. H.; Comi, G.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Wiendl, H.; Buffels, R.; Kuenzel, T.; Vermersch, P. | Journal Contribution | M |
| 29 | 2022 | Employment and cognitive improvements in ocrelizumab-treated patients with relapsing-remitting multiple sclerosis: 96-week CASTING study data | Wiendl, H.; Benedict, R. H.; Comi, G.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Buffels, R.; Kuenzel, T.; Vermersch, P. | Journal Contribution | M |
| 30 | 2022 | Walking fatigability manifests globally in several gait domains in people with multiple sclerosis during a prolonged walking | BALISTIERI SANTINELLI, Felipe; RAMARI FERREIRA, Cintia; GYSEMBERG, Griet; VAN WIJMEERSCH, Bart; Kos, D.; MEYNS, Pieter; FEYS, Peter | Journal Contribution | M |
| 31 | 2022 | Employment and Cognitive Improvements in Ocrelizumab-Treated Patients with Relapsing-Remitting Multiple Sclerosis: 96-Week CASTING Study Data | Wiendl, H.; Benedict, R.H.B.; Comi, G.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Buffels, R.; Kuenzel, T.; Vermersch, P. | Conference Material | C2 |
| 32 | 2022 | Corrigendum to Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression: [Computer Methods and Programs in Biomedicine, Volume 208, (September 2021) 106180] | DE BROUWER, Edward; BECKER, Thijs; Moreau, Yves; Havrdova, Eva Kubala; Trojano, Maria; Eichau, Sara; Ozakbas, Serkan; Onofrj, Marco; Grammond, Pierre; Kuhle, Jens; Kappos, Ludwig; Sola, Patrizia; Cartechini, Elisabetta; Lechner-Scott, Jeannette; Alroughani, Raed; Gerlach, Oliver; Kalincik, Tomas; Granella, Franco; Grand'Maison, Francois; VAN WIJMEERSCH, Bart; Bergamaschi, Roberto; Sá, Maria José; Soysal, Aysun; Sanchez-Menoyo, Jose Luis; Solaro, Claudio; Boz, Cavit; Iuliano, Gerardo; Buzzard, Katherine; Aguera-Morales, Eduardo; Terzi, Murat; Trivio, Tamara Castillo; Spitaleri, Daniele; Van Pesch, Vincent; Shaygannejad, Vahid; Moore, Fraser; Oreja-Guevara, Celia; Maimone, Davide; Gouider, Riadh; Csepany, Tunde; Ramo-Tello, Cristina; PEETERS, Liesbet | Journal Contribution | A1 |
| 33 | 2022 | Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with suboptimal response to prior disease-modifying therapies: A primary analysis from the phase 3b CASTING single-arm, open-label trial | Vermersch, Patrick; Oreja-Guevara, Celia; Siva, Aksel; VAN WIJMEERSCH, Bart; Wiendl, Heinz; Wuerfel, Jens; Buffels, Regine; Kadner, Karen; Kuenzel, Thomas; Comi, Giancarlo | Journal Contribution | A1 |
| 34 | 2022 | Motor evoked potentials for multiple sclerosis, a multiyear follow-up dataset | YPERMAN, Jan; POPESCU, Veronica; VAN WIJMEERSCH, Bart; BECKER, Thijs; PEETERS, Liesbet | Journal Contribution | A1 |
| 35 | 2022 | A real-world single-centre analysis of the safety and efficacy of cladribine tablets for relapsing multiple sclerosis | AERTS, Sofie; KHAN, Hamza; SEVERIJNS, Deborah; POPESCU, Veronica; PEETERS, Liesbet; VAN WIJMEERSCH, Bart | Journal Contribution | M |
| 36 | 2022 | A multi-stakeholder survey on multiple sclerosis multidisciplinary care: The situation in Belgium and lessons for the global community | Van Hijfte, L.; Cambron, M.; Capron, B.; Dachy, B.; Decoo, D.; Dive, D.; Dubois, B.; El Sankari, S.; London, F.; Perrotta, G.; POPESCU, Veronica; Van Pesch, V.; VAN WIJMEERSCH, Bart; Willekens, B.; Laureys, G. | Journal Contribution | M |
| 37 | 2022 | Rapamycin rescues loss-of-function in blood-brain barrier-interacting regulatory T cells | BAETEN, Paulien; HAMAD, Ibrahim; HOEKS, Cindy; Hiltensperger, Michael; VAN WIJMEERSCH, Bart; POPESCU, Veronica; Aly, Lilian; SOMERS, Veerle; Korn, Thomas; KLEINEWIETFELD, Markus; HELLINGS, Niels; BROUX, Bieke | Preprint | O |
| 38 | 2021 | Multicentric motor evoked potentials in multiple sclerosis: a retrospective pilot study | DEKEYSER, Catherine; YPERMAN, Jan; KHAN, Hamza; VAN WIJMEERSCH, Bart; Verhoeven, K.; Cambron, M.; BECKER, Thijs; Laureys, G.; PEETERS, Liesbet | Journal Contribution | M |
| 39 | 2021 | Outcomes in Alemtuzumab-Treated Patients With Thyroid Adverse Events: 6-Year Pooled CARE-MS Data | Dayan, Colin; Lecumberri, Beatriz; Muller, Ilaria; Ganesananthan, Sashiananthan; Hunter, Samuel F.; Selmaj, Krzysztof W.; Hartung, Hans-Peter; Havrdova, Eva K.; LaGanke, Christopher C.; Ziemssen, Tjalf; VAN WIJMEERSCH, Bart; Meuth, Sven G.; Margolin, David H.; Afsar, Salman; Daizadeh, Nadia; Poole, Elizabeth M.; Baker, Darren P.; Senior, Peter A. | Journal Contribution | M |
| 40 | 2021 | Efficacy and safety of ocrelizumab in patients with RRMS with suboptimal response to prior disease-modifying therapies: 3-year data from CASTING and LIBERTO 1-year interim results | VAN WIJMEERSCH, Bart; Comi, G.; Oreja-Guevara, C.; Wiendl, H.; Wuerfel, J.; Buffels, R.; Dirks, P.; Kuenzel, T.; Kadner, K.; Vermersch, P. | Journal Contribution | M |
Loading...
5
0
5
0
false